insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
123,44 USD
arrow_upward
+1,09%(+1,33) 1D
13-окт., 12:56:49 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
122,80 USD
High
123,77 USD
Low
121,04 USD
Mkt. cap
5,62 млд
Avg. vol.
676,78 миң
Volume
189,60 миң
P/E ratio
60,21
52-wk high
123,77 USD
52-wk low
48,55 USD
EPS
2,05 USD
Beta
0,61
Shares outstanding
45,50 млн
No. of employees
3 миң
Open
122,80 USD
High
123,77 USD
Low
121,04 USD
Mkt. cap
5,62 млд
Avg. vol.
676,78 миң
Volume
189,60 миң
P/E ratio
60,21
52-wk high
123,77 USD
52-wk low
48,55 USD
EPS
2,05 USD
Beta
0,61
Shares outstanding
45,50 млн
No. of employees
3 миң
News stories
From web sources and news partners
Zacks
·
3 саат мурун
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3,01 миң
Founded1971
HeadquartersБостон, Массачусетс, Америка Кошмо Штаттары
SectorMedical device
Websitehaemonetics.com